JPS6020365B2 - 組成物 - Google Patents

組成物

Info

Publication number
JPS6020365B2
JPS6020365B2 JP51025163A JP2516376A JPS6020365B2 JP S6020365 B2 JPS6020365 B2 JP S6020365B2 JP 51025163 A JP51025163 A JP 51025163A JP 2516376 A JP2516376 A JP 2516376A JP S6020365 B2 JPS6020365 B2 JP S6020365B2
Authority
JP
Japan
Prior art keywords
pge
triacetin
methyl
compound
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP51025163A
Other languages
English (en)
Japanese (ja)
Other versions
JPS51112508A (en
Inventor
ハイマン ヤーコウスキー サムエル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of JPS51112508A publication Critical patent/JPS51112508A/ja
Publication of JPS6020365B2 publication Critical patent/JPS6020365B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP51025163A 1975-03-27 1976-03-10 組成物 Expired JPS6020365B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/562,535 US3966962A (en) 1975-03-27 1975-03-27 Triacetin solutions of PGE-type compounds
US562535 1975-03-27

Publications (2)

Publication Number Publication Date
JPS51112508A JPS51112508A (en) 1976-10-05
JPS6020365B2 true JPS6020365B2 (ja) 1985-05-21

Family

ID=24246672

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51025163A Expired JPS6020365B2 (ja) 1975-03-27 1976-03-10 組成物

Country Status (11)

Country Link
US (1) US3966962A (enExample)
JP (1) JPS6020365B2 (enExample)
BE (1) BE840075A (enExample)
CA (1) CA1044140A (enExample)
DE (1) DE2611183C2 (enExample)
FR (1) FR2305177A1 (enExample)
GB (1) GB1493092A (enExample)
HK (1) HK10481A (enExample)
MX (1) MX3794E (enExample)
NL (1) NL190539C (enExample)
ZA (1) ZA761306B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU510190B2 (en) * 1976-08-14 1980-06-12 Carlson, Lars A Prostaglandin method
DE2740953A1 (de) * 1977-09-12 1979-03-22 Thera Ges Fuer Patente Verwendung von prostaglandinen zur senkung des blutzuckerspiegels
US4301175A (en) * 1980-12-29 1981-11-17 The Upjohn Company E-Type prostaglandin compositions
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
ZA835226B (en) * 1982-07-19 1985-03-27 Syntex Inc Pge-type compositions encapsulated by acid isolated gelatin
US4431833A (en) * 1982-12-27 1984-02-14 American Cyanamid Company Prostaglandin and hydroxylated fatty acid ester formulations
US4820732A (en) * 1985-10-04 1989-04-11 The Upjohn Company Method and compositions for reducing dysfunction in angioplasty procedures
US4955878A (en) * 1986-04-04 1990-09-11 Biotechnology, Inc. Kit for preventing or treating arterial dysfunction resulting from angioplasty procedures
JP3756512B2 (ja) * 1992-09-21 2006-03-15 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 徐放性タンパク質製剤
BRPI0014869B8 (pt) * 1999-10-15 2021-05-25 Sucampo Ag prostaglandinas bicíclicas, composições estabilizadas das mesmas, bem como processo para sua estabilização
US20100286101A1 (en) * 2009-05-07 2010-11-11 Jason Carbol Pharmaceutical composition including a corticosteroid and a vitamin d analog having improved stability
WO2015200444A1 (en) * 2014-06-24 2015-12-30 Saudi Arabian Oil Company Encapsulation of an acid precursor for oil field applications
US20230338322A1 (en) * 2020-05-04 2023-10-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Glyceryltriacetate (gta) for use in improving breathing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA721937B (en) * 1971-10-22 1972-12-27 Upjohn Co Pharmaceutical preparations and uses thereof
US3829579A (en) * 1971-11-01 1974-08-13 Upjohn Co Stable solutions of pge-type compounds
US3833725A (en) * 1972-12-08 1974-09-03 Syntex Corp Dialkylated glycol compositions and medicament preparations containing same
JPS5729463B2 (enExample) * 1973-12-07 1982-06-23

Also Published As

Publication number Publication date
NL190539C (nl) 1994-04-18
DE2611183C2 (de) 1985-08-14
DE2611183A1 (de) 1976-10-14
FR2305177A1 (fr) 1976-10-22
FR2305177B1 (enExample) 1982-10-08
CA1044140A (en) 1978-12-12
HK10481A (en) 1981-03-27
NL7603064A (nl) 1976-09-29
AU1194876A (en) 1977-09-15
BE840075A (fr) 1976-09-27
MX3794E (es) 1981-07-22
JPS51112508A (en) 1976-10-05
ZA761306B (en) 1977-02-23
NL190539B (nl) 1993-11-16
GB1493092A (en) 1977-11-23
US3966962A (en) 1976-06-29

Similar Documents

Publication Publication Date Title
CA2562614C (en) Use of treprostinil to treat neuropathic diabetic foot ulcers
US5153222A (en) Method of treating pulmonary hypertension with benzidine prostaglandins
US5708031A (en) Prostaglandin E2 treatment of impotence
US8071613B2 (en) Anti-constipation composition
EP0084865B1 (en) Propylene glycol diester solutions of pge-type compounds
IE52536B1 (en) Carbonate diester solutions of pge-type compounds
ES2282408T3 (es) 15-ceto-prostaglandina para el tratamiento de estreñimiento por farmaco.
JPS6020365B2 (ja) 組成物
AU752049B2 (en) Method and composition for treatment of erectile dysfunction
KR0158870B1 (ko) 폐순환 승압의 치료, 예방 또는 진단용 조성물
JP6408426B2 (ja) 胃腸障害処置用プロスタグランジン誘導体
EP0351651B1 (en) Insulin preparation
ES2310013T3 (es) Uso de compuestos de 15-ceto-prostaglandina e como antagonistas de endotelina.
US5028628A (en) Methods of treating pulmonary hypertension
AU649130B2 (en) Pharmaceutical compositions for transcutaneous administration
JP2002534389A (ja) 女性性機能障害の治療のための方法および組成物
ES2371658T3 (es) Uso combinado de compuesto de prostaglandina e inhibidor de la bomba de protones para el tratamiento de trastornos gastrointestinales.
US3882241A (en) Use of prostaglandins E and F for prevention of pregnancy in humans
CA2117285A1 (en) Use of interleukin-8
JPH02326B2 (enExample)
JPS60120995A (ja) 新規アミノ酸誘導体の製法
US3917864A (en) Use of prostaglandins E and F for induction of labor
US3899587A (en) Use of prostaglandins E and F for abortion
RU2488398C2 (ru) Фармацевтическая комбинация опиоида и простагландинового соединения
EP0309801A2 (en) Use of thromboxane A2 antagonists for the manufacture of a medicament for improving post-ischemic myocardial dysfunction